Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03030169
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
EB4 | N,N',N''-[(3S,7S,11S)-2,6,10-trioxo- 1,5,9-trioxacyclododecane-3,7,11- triyl]tris(2,3-dihydroxybenzamide) | A,B,C | 3CMP | 0.7 | |
ALE | L-EPINEPHRINE | A | 3PAH | 0.74 | |
ALE | L-EPINEPHRINE | A | 2HKK | 0.74 | |
LDP | L-DOPAMINE | A,B | 2A3R | 0.77 | |
LDP | L-DOPAMINE | A | 5PAH | 0.77 | |
LDP | L-DOPAMINE | A,B | 2QMZ | 0.77 | |
LDP | L-DOPAMINE | A,B | 2VQ5 | 0.77 | |
AED | 4-(2-aminoethyl)-2-cyclohexylphenol | A | 3BUH | 0.71 | |
PIT | PICEATANNOL | A,B,C,D,E,F, G,H,I,J,K,L, M,N | 2JJ1 | 0.72 | |
DAH | 3,4-DIHYDROXYPHENYLALANINE | A,B | 1RNR | 0.74 | |
DAH | 3,4-DIHYDROXYPHENYLALANINE | A | 6PAH | 0.74 | |
DAH | 3,4-DIHYDROXYPHENYLALANINE | A,B | 1IVV | 0.74 | |
ECA | N,N',N''-[BENZENE-1,3,5-TRIYLTRIS(METHYLENE)]TRIS(2,3- DIHYDROXYBENZAMIDE) | A,B | 2CHU | 0.75 | |
MCT | 4-METHYLCATECHOL | A | 1L4G | 0.71 | |
MCT | 4-METHYLCATECHOL | A | 2EHZ | 0.71 | |
MCT | 4-METHYLCATECHOL | A,B | 1DMH | 0.71 | |
BP7 | 1,1'-BIPHENYL-3,4-DIOL | A | 2EI0 | 0.72 | |
MOY | [(4R)-4-(3-HYDROXYPHENYL)-1,6-DIMETHYL- 2-THIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN- 5-YL](PHENYL)METHANONE | A,B | 2IEH | 0.72 | |
3XH | 3-Hydroxyhippuric acid | A | 3E9K | 0.72 | |
DHC | CAFFEIC ACID | A,B,C,D,E,F, G,H | 2O7D | 0.75 | |
DHC | CAFFEIC ACID | A | 1KOU | 0.75 | |
BPY | BIPHENYL-2,3-DIOL | A | 1KMY | 0.71 | |
BPY | BIPHENYL-2,3-DIOL | B | 1KW8 | 0.71 | |
BPY | BIPHENYL-2,3-DIOL | A | 2EI3 | 0.71 | |
BPY | BIPHENYL-2,3-DIOL | A | 1EIR | 0.71 | |
BPY | BIPHENYL-2,3-DIOL | B | 1KW6 | 0.71 | |
BPY | BIPHENYL-2,3-DIOL | B | 1KWC | 0.71 | |
BPY | BIPHENYL-2,3-DIOL | B | 1KW9 | 0.71 | |
REN | (S)-reticuline | A | 3FWA | 0.71 | |
REN | (S)-reticuline | A | 3D2D | 0.71 | |
YTT | (3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine- 2,5-dione | A | 3G5H | 0.77 | |
NLT | N-DODECANOYL-L-TYROSINE | A,B,C,D,E,F, G,H | 2G0B | 0.7 | |
LNR | L-NOREPINEPHRINE | A,B | 2QEO | 0.73 | |
LNR | L-NOREPINEPHRINE | A | 3DYE | 0.73 | |
LNR | L-NOREPINEPHRINE | A | 4PAH | 0.73 | |
TY3 | 3-HYDROXY-L-TYROSINE | A,B | 2VH3 | 0.74 | |
B3Y | (3S)-3-AMINO-4-(4-HYDROXYPHENYL)BUTANOIC ACID | A | 3HF0 | 0.71 | |
B3Y | (3S)-3-AMINO-4-(4-HYDROXYPHENYL)BUTANOIC ACID | A | 2OXK | 0.71 | |
B3Y | (3S)-3-AMINO-4-(4-HYDROXYPHENYL)BUTANOIC ACID | A,B,C | 2OXJ | 0.71 | |
AEF | 4-(2-aminoethyl)phenol | A | 3BRA | 0.72 | |
Y12 | 4-{(1E)-3-OXO-3-[(2-PHENYLETHYL)AMINO]PROP- 1-EN-1-YL}-1,2-PHENYLENE DIACETATE | A | 2EW5 | 0.74 | |
LOB | LOBELINE | A,B,C,D,E,F, G,H,I,J | 2BYS | 0.7 | |
Y13 | (2E)-3-(3,4-DIHYDROXYPHENYL)-N- [2-(4-HYDROXYPHENYL)ETHYL]ACRYLAMIDE | A | 2EW6 | 0.9 |